Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Schiff

Showing results (61-70 of 199) with videos related to

Pageof 20
Sort By:
Current Oncology Reports|April 5, 2017
The Evolving Role of the Estrogen Receptor Mutations in Endocrine Therapy-Resistant Breast CancerRinath Jeselsohn, Carmine De Angelis, Myles Brown, et al.
Endocrine Reviews|January 25, 2008
Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistanceGrazia Arpino, Lisa Wiechmann, C Kent Osborne, et al.
Brain and Language|October 13, 2015
Word and line bisection in typical and impaired readers and a cross-language comparisonYafit Gabay, Shai Gabay, Avishai Henik, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|October 3, 2013
Visuospatial attention deficits in developmental dyslexia: evidence from visual and mental number line bisection tasksYafit Gabay, Shai Gabay, Rachel Schiff, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|December 4, 2025
What Predicts Listening Comprehension in Standard Arabic? The Interdependence of Linguistic and Metalinguistic Skills in Spoken and Standard ArabicLina Haj, Elinor Saiegh-Haddad, Ola Ghawi-Dakwar, et al.
Nature Reviews. Clinical Oncology|July 1, 2015
ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancerRinath Jeselsohn, Gilles Buchwalter, Carmine De Angelis, et al.
Breast Cancer Research and Treatment|September 13, 2021
Management of hormone receptor-positive, human epidermal growth factor 2-negative metastatic breast cancerJason A Mouabbi, C Kent Osborne, Rachel Schiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2022
Elacestrant and the Promise of Oral SERDsKatherine G Sanchez, Julie R Nangia, Rachel Schiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapyXiaojiang Cui, Rachel Schiff, Grazia Arpino, et al.
Breast (Edinburgh, Scotland)|August 15, 2015
The changing role of ER in endocrine resistanceAgostina Nardone, Carmine De Angelis, Meghana V Trivedi, et al.
Pageof 20

Showing results (61-70 of 199) with videos related to

Sort By:
Pageof 20
Current Oncology Reports|April 5, 2017
The Evolving Role of the Estrogen Receptor Mutations in Endocrine Therapy-Resistant Breast CancerRinath Jeselsohn, Carmine De Angelis, Myles Brown, et al.
Endocrine Reviews|January 25, 2008
Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistanceGrazia Arpino, Lisa Wiechmann, C Kent Osborne, et al.
Brain and Language|October 13, 2015
Word and line bisection in typical and impaired readers and a cross-language comparisonYafit Gabay, Shai Gabay, Avishai Henik, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|October 3, 2013
Visuospatial attention deficits in developmental dyslexia: evidence from visual and mental number line bisection tasksYafit Gabay, Shai Gabay, Rachel Schiff, et al.
Journal of Speech, Language, and Hearing Research : JSLHR|December 4, 2025
What Predicts Listening Comprehension in Standard Arabic? The Interdependence of Linguistic and Metalinguistic Skills in Spoken and Standard ArabicLina Haj, Elinor Saiegh-Haddad, Ola Ghawi-Dakwar, et al.
Nature Reviews. Clinical Oncology|July 1, 2015
ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancerRinath Jeselsohn, Gilles Buchwalter, Carmine De Angelis, et al.
Breast Cancer Research and Treatment|September 13, 2021
Management of hormone receptor-positive, human epidermal growth factor 2-negative metastatic breast cancerJason A Mouabbi, C Kent Osborne, Rachel Schiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2022
Elacestrant and the Promise of Oral SERDsKatherine G Sanchez, Julie R Nangia, Rachel Schiff, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapyXiaojiang Cui, Rachel Schiff, Grazia Arpino, et al.
Breast (Edinburgh, Scotland)|August 15, 2015
The changing role of ER in endocrine resistanceAgostina Nardone, Carmine De Angelis, Meghana V Trivedi, et al.
Pageof 20